▶ 調査レポート

バイオバンク管理システムの世界市場見通し2023年-2029年

• 英文タイトル:Biobank Management Systems Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが調査・発行した産業分析レポートです。バイオバンク管理システムの世界市場見通し2023年-2029年 / Biobank Management Systems Market, Global Outlook and Forecast 2023-2029 / MRC2312MG01449資料のイメージです。• レポートコード:MRC2312MG01449
• 出版社/出版日:Market Monitor Global / 2023年12月
• レポート形態:英文、PDF、119ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥487,500 (USD3,250)▷ お問い合わせ
  Enterprise User¥731,250 (USD4,875)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートは次の情報を含め、世界のバイオバンク管理システム市場規模と予測を収録しています。・世界のバイオバンク管理システム市場:売上、2018年-2023年、2024年-2029年
・世界のバイオバンク管理システム市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバイオバンク管理システム市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「クラウド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

バイオバンク管理システムのグローバル主要企業は、Thermo Fisher Scientific、 Agilent Technologies、 Autoscribe Informatics、 DiData、 AgileBio、 CloudLIMS、 Modul-Bio、 TD Biobank、 OpenSpecimen、 Information Management Services、 Azenta、 BBMS、 LabKey、 FreeLIMS、 LabWare、 Titian、 Octalsoft、 Interactive Software、 eLabNext、 SoftSystem、 STARLIMS、 NEST、 Origincell、 Improve Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、バイオバンク管理システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のバイオバンク管理システム市場:タイプ別、2018年-2023年、2024年-2029年
世界のバイオバンク管理システム市場:タイプ別市場シェア、2022年
・クラウド、オンプレミス

世界のバイオバンク管理システム市場:用途別、2018年-2023年、2024年-2029年
世界のバイオバンク管理システム市場:用途別市場シェア、2022年
・医療、製薬、研究所、CRO、その他

世界のバイオバンク管理システム市場:地域・国別、2018年-2023年、2024年-2029年
世界のバイオバンク管理システム市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるバイオバンク管理システムのグローバル売上、2018年-2023年
・主要企業におけるバイオバンク管理システムのグローバル売上シェア、2022年
・主要企業におけるバイオバンク管理システムのグローバル販売量、2018年-2023年
・主要企業におけるバイオバンク管理システムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Thermo Fisher Scientific、 Agilent Technologies、 Autoscribe Informatics、 DiData、 AgileBio、 CloudLIMS、 Modul-Bio、 TD Biobank、 OpenSpecimen、 Information Management Services、 Azenta、 BBMS、 LabKey、 FreeLIMS、 LabWare、 Titian、 Octalsoft、 Interactive Software、 eLabNext、 SoftSystem、 STARLIMS、 NEST、 Origincell、 Improve Medical

*************************************************************

・調査・分析レポートの概要
バイオバンク管理システム市場の定義
市場セグメント
世界のバイオバンク管理システム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバイオバンク管理システム市場規模
世界のバイオバンク管理システム市場規模:2022年 VS 2029年
世界のバイオバンク管理システム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバイオバンク管理システムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバイオバンク管理システム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:クラウド、オンプレミス
バイオバンク管理システムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:医療、製薬、研究所、CRO、その他
バイオバンク管理システムの用途別グローバル売上・予測

・地域別市場分析
地域別バイオバンク管理システム市場規模 2022年と2029年
地域別バイオバンク管理システム売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Thermo Fisher Scientific、 Agilent Technologies、 Autoscribe Informatics、 DiData、 AgileBio、 CloudLIMS、 Modul-Bio、 TD Biobank、 OpenSpecimen、 Information Management Services、 Azenta、 BBMS、 LabKey、 FreeLIMS、 LabWare、 Titian、 Octalsoft、 Interactive Software、 eLabNext、 SoftSystem、 STARLIMS、 NEST、 Origincell、 Improve Medical
...

This research report provides a comprehensive analysis of the Biobank Management Systems market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biobank Management Systems market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biobank Management Systems, challenges faced by the industry, and potential opportunities for market players.
The global Biobank Management Systems market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biobank Management Systems market presents opportunities for various stakeholders, including Medical, Pharmaceutical. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biobank Management Systems market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biobank Management Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.
Key Features:
The research report on the Biobank Management Systems market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biobank Management Systems market.
Market Overview: The report provides a comprehensive overview of the Biobank Management Systems market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cloud, On-Premises), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biobank Management Systems market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biobank Management Systems market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biobank Management Systems market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biobank Management Systems market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biobank Management Systems market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biobank Management Systems market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biobank Management Systems, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biobank Management Systems market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biobank Management Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cloud
On-Premises
Market segment by Application
Medical
Pharmaceutical
Laboratory
CRO
Others
Global Biobank Management Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Thermo Fisher Scientific
Agilent Technologies
Autoscribe Informatics
DiData
AgileBio
CloudLIMS
Modul-Bio
TD Biobank
OpenSpecimen
Information Management Services
Azenta
BBMS
LabKey
FreeLIMS
LabWare
Titian
Octalsoft
Interactive Software
eLabNext
SoftSystem
STARLIMS
NEST
Origincell
Improve Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biobank Management Systems, market overview.
Chapter 2: Global Biobank Management Systems market size in revenue.
Chapter 3: Detailed analysis of Biobank Management Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biobank Management Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Biobank Management Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biobank Management Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biobank Management Systems Overall Market Size
2.1 Global Biobank Management Systems Market Size: 2022 VS 2029
2.2 Global Biobank Management Systems Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biobank Management Systems Players in Global Market
3.2 Top Global Biobank Management Systems Companies Ranked by Revenue
3.3 Global Biobank Management Systems Revenue by Companies
3.4 Top 3 and Top 5 Biobank Management Systems Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biobank Management Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biobank Management Systems Players in Global Market
3.6.1 List of Global Tier 1 Biobank Management Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Biobank Management Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Biobank Management Systems Market Size Markets, 2022 & 2029
4.1.2 Cloud
4.1.3 On-Premises
4.2 By Type – Global Biobank Management Systems Revenue & Forecasts
4.2.1 By Type – Global Biobank Management Systems Revenue, 2018-2023
4.2.2 By Type – Global Biobank Management Systems Revenue, 2024-2029
4.2.3 By Type – Global Biobank Management Systems Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biobank Management Systems Market Size, 2022 & 2029
5.1.2 Medical
5.1.3 Pharmaceutical
5.1.4 Laboratory
5.1.5 CRO
5.1.6 Others
5.2 By Application – Global Biobank Management Systems Revenue & Forecasts
5.2.1 By Application – Global Biobank Management Systems Revenue, 2018-2023
5.2.2 By Application – Global Biobank Management Systems Revenue, 2024-2029
5.2.3 By Application – Global Biobank Management Systems Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Biobank Management Systems Market Size, 2022 & 2029
6.2 By Region – Global Biobank Management Systems Revenue & Forecasts
6.2.1 By Region – Global Biobank Management Systems Revenue, 2018-2023
6.2.2 By Region – Global Biobank Management Systems Revenue, 2024-2029
6.2.3 By Region – Global Biobank Management Systems Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Biobank Management Systems Revenue, 2018-2029
6.3.2 US Biobank Management Systems Market Size, 2018-2029
6.3.3 Canada Biobank Management Systems Market Size, 2018-2029
6.3.4 Mexico Biobank Management Systems Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Biobank Management Systems Revenue, 2018-2029
6.4.2 Germany Biobank Management Systems Market Size, 2018-2029
6.4.3 France Biobank Management Systems Market Size, 2018-2029
6.4.4 U.K. Biobank Management Systems Market Size, 2018-2029
6.4.5 Italy Biobank Management Systems Market Size, 2018-2029
6.4.6 Russia Biobank Management Systems Market Size, 2018-2029
6.4.7 Nordic Countries Biobank Management Systems Market Size, 2018-2029
6.4.8 Benelux Biobank Management Systems Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Biobank Management Systems Revenue, 2018-2029
6.5.2 China Biobank Management Systems Market Size, 2018-2029
6.5.3 Japan Biobank Management Systems Market Size, 2018-2029
6.5.4 South Korea Biobank Management Systems Market Size, 2018-2029
6.5.5 Southeast Asia Biobank Management Systems Market Size, 2018-2029
6.5.6 India Biobank Management Systems Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Biobank Management Systems Revenue, 2018-2029
6.6.2 Brazil Biobank Management Systems Market Size, 2018-2029
6.6.3 Argentina Biobank Management Systems Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Biobank Management Systems Revenue, 2018-2029
6.7.2 Turkey Biobank Management Systems Market Size, 2018-2029
6.7.3 Israel Biobank Management Systems Market Size, 2018-2029
6.7.4 Saudi Arabia Biobank Management Systems Market Size, 2018-2029
6.7.5 UAE Biobank Management Systems Market Size, 2018-2029
7 Biobank Management Systems Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Biobank Management Systems Major Product Offerings
7.1.4 Thermo Fisher Scientific Biobank Management Systems Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Company Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Biobank Management Systems Major Product Offerings
7.2.4 Agilent Technologies Biobank Management Systems Revenue in Global Market (2018-2023)
7.2.5 Agilent Technologies Key News & Latest Developments
7.3 Autoscribe Informatics
7.3.1 Autoscribe Informatics Company Summary
7.3.2 Autoscribe Informatics Business Overview
7.3.3 Autoscribe Informatics Biobank Management Systems Major Product Offerings
7.3.4 Autoscribe Informatics Biobank Management Systems Revenue in Global Market (2018-2023)
7.3.5 Autoscribe Informatics Key News & Latest Developments
7.4 DiData
7.4.1 DiData Company Summary
7.4.2 DiData Business Overview
7.4.3 DiData Biobank Management Systems Major Product Offerings
7.4.4 DiData Biobank Management Systems Revenue in Global Market (2018-2023)
7.4.5 DiData Key News & Latest Developments
7.5 AgileBio
7.5.1 AgileBio Company Summary
7.5.2 AgileBio Business Overview
7.5.3 AgileBio Biobank Management Systems Major Product Offerings
7.5.4 AgileBio Biobank Management Systems Revenue in Global Market (2018-2023)
7.5.5 AgileBio Key News & Latest Developments
7.6 CloudLIMS
7.6.1 CloudLIMS Company Summary
7.6.2 CloudLIMS Business Overview
7.6.3 CloudLIMS Biobank Management Systems Major Product Offerings
7.6.4 CloudLIMS Biobank Management Systems Revenue in Global Market (2018-2023)
7.6.5 CloudLIMS Key News & Latest Developments
7.7 Modul-Bio
7.7.1 Modul-Bio Company Summary
7.7.2 Modul-Bio Business Overview
7.7.3 Modul-Bio Biobank Management Systems Major Product Offerings
7.7.4 Modul-Bio Biobank Management Systems Revenue in Global Market (2018-2023)
7.7.5 Modul-Bio Key News & Latest Developments
7.8 TD Biobank
7.8.1 TD Biobank Company Summary
7.8.2 TD Biobank Business Overview
7.8.3 TD Biobank Biobank Management Systems Major Product Offerings
7.8.4 TD Biobank Biobank Management Systems Revenue in Global Market (2018-2023)
7.8.5 TD Biobank Key News & Latest Developments
7.9 OpenSpecimen
7.9.1 OpenSpecimen Company Summary
7.9.2 OpenSpecimen Business Overview
7.9.3 OpenSpecimen Biobank Management Systems Major Product Offerings
7.9.4 OpenSpecimen Biobank Management Systems Revenue in Global Market (2018-2023)
7.9.5 OpenSpecimen Key News & Latest Developments
7.10 Information Management Services
7.10.1 Information Management Services Company Summary
7.10.2 Information Management Services Business Overview
7.10.3 Information Management Services Biobank Management Systems Major Product Offerings
7.10.4 Information Management Services Biobank Management Systems Revenue in Global Market (2018-2023)
7.10.5 Information Management Services Key News & Latest Developments
7.11 Azenta
7.11.1 Azenta Company Summary
7.11.2 Azenta Business Overview
7.11.3 Azenta Biobank Management Systems Major Product Offerings
7.11.4 Azenta Biobank Management Systems Revenue in Global Market (2018-2023)
7.11.5 Azenta Key News & Latest Developments
7.12 BBMS
7.12.1 BBMS Company Summary
7.12.2 BBMS Business Overview
7.12.3 BBMS Biobank Management Systems Major Product Offerings
7.12.4 BBMS Biobank Management Systems Revenue in Global Market (2018-2023)
7.12.5 BBMS Key News & Latest Developments
7.13 LabKey
7.13.1 LabKey Company Summary
7.13.2 LabKey Business Overview
7.13.3 LabKey Biobank Management Systems Major Product Offerings
7.13.4 LabKey Biobank Management Systems Revenue in Global Market (2018-2023)
7.13.5 LabKey Key News & Latest Developments
7.14 FreeLIMS
7.14.1 FreeLIMS Company Summary
7.14.2 FreeLIMS Business Overview
7.14.3 FreeLIMS Biobank Management Systems Major Product Offerings
7.14.4 FreeLIMS Biobank Management Systems Revenue in Global Market (2018-2023)
7.14.5 FreeLIMS Key News & Latest Developments
7.15 LabWare
7.15.1 LabWare Company Summary
7.15.2 LabWare Business Overview
7.15.3 LabWare Biobank Management Systems Major Product Offerings
7.15.4 LabWare Biobank Management Systems Revenue in Global Market (2018-2023)
7.15.5 LabWare Key News & Latest Developments
7.16 Titian
7.16.1 Titian Company Summary
7.16.2 Titian Business Overview
7.16.3 Titian Biobank Management Systems Major Product Offerings
7.16.4 Titian Biobank Management Systems Revenue in Global Market (2018-2023)
7.16.5 Titian Key News & Latest Developments
7.17 Octalsoft
7.17.1 Octalsoft Company Summary
7.17.2 Octalsoft Business Overview
7.17.3 Octalsoft Biobank Management Systems Major Product Offerings
7.17.4 Octalsoft Biobank Management Systems Revenue in Global Market (2018-2023)
7.17.5 Octalsoft Key News & Latest Developments
7.18 Interactive Software
7.18.1 Interactive Software Company Summary
7.18.2 Interactive Software Business Overview
7.18.3 Interactive Software Biobank Management Systems Major Product Offerings
7.18.4 Interactive Software Biobank Management Systems Revenue in Global Market (2018-2023)
7.18.5 Interactive Software Key News & Latest Developments
7.19 eLabNext
7.19.1 eLabNext Company Summary
7.19.2 eLabNext Business Overview
7.19.3 eLabNext Biobank Management Systems Major Product Offerings
7.19.4 eLabNext Biobank Management Systems Revenue in Global Market (2018-2023)
7.19.5 eLabNext Key News & Latest Developments
7.20 SoftSystem
7.20.1 SoftSystem Company Summary
7.20.2 SoftSystem Business Overview
7.20.3 SoftSystem Biobank Management Systems Major Product Offerings
7.20.4 SoftSystem Biobank Management Systems Revenue in Global Market (2018-2023)
7.20.5 SoftSystem Key News & Latest Developments
7.21 STARLIMS
7.21.1 STARLIMS Company Summary
7.21.2 STARLIMS Business Overview
7.21.3 STARLIMS Biobank Management Systems Major Product Offerings
7.21.4 STARLIMS Biobank Management Systems Revenue in Global Market (2018-2023)
7.21.5 STARLIMS Key News & Latest Developments
7.22 NEST
7.22.1 NEST Company Summary
7.22.2 NEST Business Overview
7.22.3 NEST Biobank Management Systems Major Product Offerings
7.22.4 NEST Biobank Management Systems Revenue in Global Market (2018-2023)
7.22.5 NEST Key News & Latest Developments
7.23 Origincell
7.23.1 Origincell Company Summary
7.23.2 Origincell Business Overview
7.23.3 Origincell Biobank Management Systems Major Product Offerings
7.23.4 Origincell Biobank Management Systems Revenue in Global Market (2018-2023)
7.23.5 Origincell Key News & Latest Developments
7.24 Improve Medical
7.24.1 Improve Medical Company Summary
7.24.2 Improve Medical Business Overview
7.24.3 Improve Medical Biobank Management Systems Major Product Offerings
7.24.4 Improve Medical Biobank Management Systems Revenue in Global Market (2018-2023)
7.24.5 Improve Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer